Tri-staple 2.0 Reloads +3 more— 510(k) K253657

Substantially Equivalent

Covidien (Part of Medtronic)

FDA 510(k) clearance K253657 for Tri-staple 2.0 Reloads +3 more, Substantially Equivalent on 2026-04-10. Applicant: Covidien (Part of Medtronic). Device class: 2.

Summary

This clearance covers four families of stapler reloads from Medtronic's Covidien unit: Tri-Staple 2.0 reloads, Endo GIA reloads with Tri-Staple technology, Endo GIA gray articulating reloads, and Signia small diameter reloads. Reloads are the disposable staple cartridges that load into the stapler. Product code GDW covers implantable staples.

Class II, 21 CFR 878.4750. The General and Plastic Surgery panel reviewed it as a Traditional 510(k).

Covidien filed from North Haven, Connecticut. Review took 141 days (November 20, 2025 to April 10, 2026). Reload filings are routine for stapler makers, since new cartridge sizes and staple configurations each need clearance.

Clearance details

Device name as filed
Tri-staple 2.0 Reloads; Endo GIA Reloads with Tri-Staple Technology; Endo GIA Gray Articulating Reloads; Signia Small Diameter Reloads
Applicant
Covidien (Part of Medtronic)
Product code
Code GDW
Device class
Class 2
Regulation
21 CFR 878.4750
Advisory panel
General, Plastic Surgery
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
North Haven, CT, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code GDW

view all

More clearances from Covidien (Part of Medtronic)

view all

Adverse events under product code GDW

product code GDW
Death
450
Injury
12,684
Malfunction
68,730
Other
6
Total
81,870

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.